Delivery Order SPE2DB25D3306-SPE2DB25FUCQC
- Not listed
- The Defense Logistics Agency awarded a $2,843.74 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Hysingla ER 40 mg tablets (60-count). This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed as a child contract...
- This federal contract award, valued at $2,434.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,177,973 units of the prescription medication HYSINGLA ER 20 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,070.48 firm fixed-price delivery order is for the supply of HYSINGLA ER 20 MG TABLET 60S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,030.71, is a delivery order for HYSINGLA ER TABS 40MG, a type of extended-release hydrocodone medication. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,631.74 firm fixed-price contract is for the supply of Hysingla ER 30 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- The Defense Logistics Agency Troop Support Medical awarded a $233,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561487735 Hysingla ER 20 mg tablets. Under this contract, Amerisourcebergen will deliver 60 tablets to a location in Conshohocken, Pennsylvania by July 13, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring pharmaceuticals and other medical supplies to support troops. No...
- This federal contract award, valued at $1,277.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Hysingla ER 60 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDXY7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,105.69, is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 7, 2025 and was awarded on February 6, 2025. It is a Firm Fixed Price contract with no...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $949.47 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 60 tablets of 30mg Hysingla ER. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 1-2, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued under the DLA Troop Support...
- This delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Amerisourcebergen Drug Corp for the supply of 4561791558 Hysingla ER 40 mg tablets. Under the terms of the firm fixed price contract valued at $758.22, Amerisourcebergen will deliver 60 tablets to a facility located in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. No major subcontractors or set aside designations were identified. The DLA manages the global supply...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCQCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,725.21 to AmerisourceBergen Drug Corp for HYSINGLA ER 20 mg tablets (60-count) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, the company's headquarters location. HYSINGLA ER is an extended-release opioid medication used for pain management, reflecting the breadth of pharmaceutical commodities AmerisourceBergen supplies to support military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills delivery orders across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The parent IDC serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a key supplier in the DLA's pharmaceutical supply chain supporting military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/13/25 |